HEICO's actual results may differ materially from those expressed in or implied by those forward-looking statements. Factors ...

Himax Technologies, Inc. (Nasdaq: HIMX) (“Himax”), a leading supplier and fabless manufacturer of display drivers and other semiconductor products, and Vuzix® Corporation (NASDAQ: VUZI), ("Vuzix"), a ...

DOVER, Del.--(BUSINESS WIRE)--Clariti, the leading provider of community development solutions for governments of all sizes, has acquired CivCheck, the first AI plan review platform capable of ...

U.S. Sen. Patty Murray plans to introduce legislation Monday in an effort to halt a federal pilot program that would add AI reviews to Medicare approvals in some states, including Washington. The bill ...

Republicans in the House advanced several permitting bills this week, fueling the bipartisan effort to pass significant reforms to the federal environmental review and approval process for energy and ...

The MarketWatch News Department was not involved in the creation of this content. The new feature streamlines key contract workflows, from supplier onboarding to contract renewals, by automating ...

The new feature streamlines key contract workflows, from supplier onboarding to contract renewals, by automating approvals, alerts, and providing end-to-end process visibility Euna Solutions®, a ...

The FDA’s reported plan to move toward single-trial approvals has stirred industry concern, but one group of analysts views the proposal as a catalyst for greater R&D investment in the sector. Earlier ...

Lizzy Lawrence leads STAT’s coverage of the Food and Drug Administration. She was previously a medical devices reporter. You can reach Lizzy on Signal at lizzylaw.53. WASHINGTON — The Food and Drug ...

Roflumilast is now approved for atopic dermatitis in children aged 2-5, showing rapid skin clearance and safety in trials. Upadacitinib's label was expanded for IBD, supported by trials showing ...